The cyclophilin inhibitor Debio-025 is a potent inhibitor of hepatitis C virus replication in vitro with a unique resistance profile

被引：7
|
作者：
Coelmont, Lotte
Paeshuyse, Jan
Kaptein, Suzanne
Vliegen, Inge
Kaul, Artur
De Clercq, Erik
Rosenwirth, Brigitte
Scalfaro, Pietro
Crabbe, Raf
Bartenschlager, Ralf
Dumont, Jean-Maurice
Neyts, Johan
机构：
[1] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium
[2] Univ Heidelberg, Heidelberg, Germany
[3] Debiopharm, Lausanne, Switzerland
[4] Med Univ Wien, Vienna, Austria
来源：
ANTIVIRAL RESEARCH | 2007年 / 74卷 / 03期
关键词：
D O I：
10.1016/j.antiviral.2007.01.037
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
29
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [31] In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6
    Dvory-Sobol, Hadas
    Han, Bin
    Lu, Julia
    Yu, Mei
    Beran, Rudolf K.
    Cheng, Guofeng
    Martin, Ross
    Svarovskaia, Evguenia
    Mo, Hongmei
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (08) : 991 - 1001
  • [32] Robustaflavone, a naturally occurring biflavanoid, is a potent inhibitor of hepatitis B virus replication
    Lin, YM
    Anderson, HM
    Schure, RM
    Korba, BE
    Flavin, MT
    Zembower, DE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 263 - MEDI
  • [33] Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus
    Beran, Rudolf K. F.
    Sharma, Ruchi
    Corsa, Amoreena C.
    Tian, Yang
    Golde, Justin
    Lundgaard, Greta
    Delaney, William E.
    Zhong, Weidong
    Greenstein, Andrew E.
    PLOS ONE, 2012, 7 (02):
  • [34] Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo
    Frey, A.
    Ecker, E. -M.
    Piras-Straub, K.
    Walker, A.
    Hofmann, T. G.
    Timm, J.
    Singer, B. B.
    Gerken, G.
    Herzer, K.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1947 - 1955
  • [35] Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro
    Lin, YM
    Zembower, DE
    Flavin, MT
    Schure, RM
    Anderson, HM
    Korba, BE
    Chen, FC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (17) : 2325 - 2328
  • [36] IN VIVO AND IN VITRO RESISTANCE TO SILIBININ, A COMPONENT OF SILYMARIN AND POTENT INHIBITOR OF HCV REPLICATION
    Chevaliez, S.
    Ahmed-Belkacem, A.
    Soulier, A.
    Zinober, K.
    Scherzer, T. -M.
    Brillet, R.
    Ferenci, P.
    Pawlotsky, J. -M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S289 - S290
  • [37] Artemisinin Analogues as Potent Inhibitors of In Vitro Hepatitis C Virus Replication
    Obeid, Susan
    Alen, Jo
    Van Hung Nguyen
    Van Cuong Pham
    Meuleman, Philip
    Pannecouque, Christophe
    Thanh Nguyen Le
    Neyts, Johan
    Dehaen, Wim
    Paeshuyse, Jan
    PLOS ONE, 2013, 8 (12):
  • [38] The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes
    Hopkins, Sam
    Bobardt, Michael
    Chatterji, Udayan
    Garcia-Rivera, Jose A.
    Lim, Precious
    Gallay, Philippe A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3888 - 3897
  • [39] The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction
    Quarato, Giovanni
    D'Aprile, Annamaria
    Gavillet, Bruno
    Vuagniaux, Gregoire
    Moradpour, Darius
    Capitanio, Nazzareno
    Piccoli, Claudia
    HEPATOLOGY, 2012, 55 (05) : 1333 - 1343
  • [40] Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
    Chen, Chih-Ming
    He, Yupeng
    Lu, Liangjun
    Ben Lim, Hock
    Tripathi, Rakesh L.
    Middleton, Tim
    Hernandez, Lisa E.
    Beno, David W. A.
    Long, Michelle A.
    Kati, Warren M.
    Bosse, Todd D.
    Larson, Daniel P.
    Wagner, Rolf
    Lanford, Robert E.
    Kohlbrenner, William E.
    Kempf, Dale J.
    Pilot-Matias, Tami J.
    Molla, Akhteruzzaman
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) : 4290 - 4296
12345